Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that ...

The holidays are known for putting a wrench in health and wellness goals. From cocktail toasts to indulgent meals and ...

Medical science confirms our bodies naturally detoxify daily through organs like the liver and kidneys. Extreme fad detoxes, ...

Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type II ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...

From fitness goals to cutting back on sugar, there's no shortage of new year resolutions. Today, we’re sitting down with Dr.

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed ...

That's why after dinner, Al and his wife have the habit of taking a quick walk — a healthy finish to a healthy meal. Research ...

What does "transformation" really mean? A new national survey from Orangetheory Fitness (OTF) reveals that, even as weight-loss medications dominate headlines, people across the country are craving ...